Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
37 /100
MEDIUM RISK
Score updated Aug 28, 2026

IPHA — Innate Pharma S.A. Dilution Risk Tracker

Track IPHA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IPHA — Get alerts when the score changes →

As of August 28, 2026, Innate Pharma S.A. (IPHA) has a DilutionWatch DilutionScore of 37/100, rated MEDIUM dilution risk. Innate Pharma S.A. has a market capitalization of $171.84M, 93.72M shares outstanding.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
17
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 15%
🔄 Reverse Split model est. 30%
• 50-day avg $1.53 approaching $1 threshold
🔔 Track IPHA — Get forecast alerts →

Market Data

Market Cap$171.84M
Shares Outstanding93.72M
Float65.91M
Cash$40.00M
Debt$26.32M
Short InterestN/A

Institutional Holdings

0.5% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track IPHA for full holder detail →

Short Interest

Short Interest152.4K
Days to Cover27.5
% of Float0.2%
FINRA data as of Jul 31, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news
Track IPHA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking IPHA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

AAT AATC AEHR AEMRF AGGID AGM AHRT AIJTY ALDX ALOT

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for IPHA
IPHA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.